The changing prevalence of ADHD? A systematic review.

IF 4.9 2区 医学 Q1 CLINICAL NEUROLOGY
Journal of affective disorders Pub Date : 2025-11-01 Epub Date: 2025-05-18 DOI:10.1016/j.jad.2025.119427
Alex F Martin, G James Rubin, M Brooke Rogers, Simon Wessely, Neil Greenberg, Charlotte E Hall, Angie Pitt, Poppy Ellis Logan, Rebecca Lucas, Samantha K Brooks
{"title":"The changing prevalence of ADHD? A systematic review.","authors":"Alex F Martin, G James Rubin, M Brooke Rogers, Simon Wessely, Neil Greenberg, Charlotte E Hall, Angie Pitt, Poppy Ellis Logan, Rebecca Lucas, Samantha K Brooks","doi":"10.1016/j.jad.2025.119427","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Understanding the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) and changes in demand for related healthcare services is crucial for effective healthcare policy and resource allocation. Clinicians, teachers and charities have reported increasing demand for ADHD assessments in recent years, overwhelming support systems. This review synthesises post-2020 studies of ADHD prevalence and incidence.</p><p><strong>Methods: </strong>We conducted systematic searches in Web of Science, Embase, Medline, Global Health, and PsycInfo using terms relating to ADHD and prevalence. Additional sources included public health databases, Google, and study reference lists. Studies were included if they contained original data relating to general population rates of ADHD and we extracted data relating to methods of assessment and measures of prevalence and incidence. We followed PRISMA and synthesis without meta-analysis (SWiM) guidelines.</p><p><strong>Results: </strong>Forty studies across 17 countries, with one study spanning 42 countries, were reviewed. No significant rise in ADHD prevalence was found, although incidence was found to vary during the COVID-19 pandemic. Only four of the included studies were at low risk of bias.</p><p><strong>Limitations: </strong>There are substantial limitations in the quality of the literature included in this review. Due to significant delays in reporting prevalence data, estimates from previous reviews may be inaccurate. There is a lack of healthcare data and no school-level data.</p><p><strong>Conclusions: </strong>Significant research gaps exist in determining ADHD prevalence and incidence. The highest quality findings do not suggest an increase in prevalence since 2020 but indicate some variability in incidence during the COVID-19 pandemic. Further research is urgently needed to guide clinical practice and public health policy.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"119427"},"PeriodicalIF":4.9000,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jad.2025.119427","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/18 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Understanding the prevalence of Attention Deficit Hyperactivity Disorder (ADHD) and changes in demand for related healthcare services is crucial for effective healthcare policy and resource allocation. Clinicians, teachers and charities have reported increasing demand for ADHD assessments in recent years, overwhelming support systems. This review synthesises post-2020 studies of ADHD prevalence and incidence.

Methods: We conducted systematic searches in Web of Science, Embase, Medline, Global Health, and PsycInfo using terms relating to ADHD and prevalence. Additional sources included public health databases, Google, and study reference lists. Studies were included if they contained original data relating to general population rates of ADHD and we extracted data relating to methods of assessment and measures of prevalence and incidence. We followed PRISMA and synthesis without meta-analysis (SWiM) guidelines.

Results: Forty studies across 17 countries, with one study spanning 42 countries, were reviewed. No significant rise in ADHD prevalence was found, although incidence was found to vary during the COVID-19 pandemic. Only four of the included studies were at low risk of bias.

Limitations: There are substantial limitations in the quality of the literature included in this review. Due to significant delays in reporting prevalence data, estimates from previous reviews may be inaccurate. There is a lack of healthcare data and no school-level data.

Conclusions: Significant research gaps exist in determining ADHD prevalence and incidence. The highest quality findings do not suggest an increase in prevalence since 2020 but indicate some variability in incidence during the COVID-19 pandemic. Further research is urgently needed to guide clinical practice and public health policy.

ADHD患病率的变化?系统回顾。
前言:了解注意缺陷多动障碍(ADHD)的患病率和相关医疗服务需求的变化对有效的医疗政策和资源配置至关重要。临床医生、教师和慈善机构报告说,近年来对多动症诊断的需求不断增加,使支持系统不堪重负。本综述综合了2020年后ADHD患病率和发病率的研究。方法:我们在Web of Science, Embase, Medline, Global Health和PsycInfo中使用与ADHD及其患病率相关的术语进行了系统搜索。其他来源包括公共卫生数据库、谷歌和研究参考列表。如果研究包含与一般人群ADHD发病率相关的原始数据,我们将其纳入研究,并提取与评估方法和患病率和发病率测量相关的数据。我们遵循PRISMA和综合无荟萃分析(SWiM)指南。结果:回顾了17个国家的40项研究,其中一项研究跨越42个国家。尽管在COVID-19大流行期间发现发病率有所不同,但ADHD患病率没有显著上升。纳入的研究中只有4项是低偏倚风险的。局限性:本综述中纳入的文献质量存在实质性的局限性。由于报告流行率数据的严重延迟,以前审查的估计可能不准确。缺乏医疗保健数据,也没有学校层面的数据。结论:在确定ADHD患病率和发病率方面存在显著的研究空白。最高质量的调查结果并不表明自2020年以来患病率增加,但表明在2019冠状病毒病大流行期间发病率存在一些差异。迫切需要进一步的研究来指导临床实践和公共卫生政策。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of affective disorders
Journal of affective disorders 医学-精神病学
CiteScore
10.90
自引率
6.10%
发文量
1319
审稿时长
9.3 weeks
期刊介绍: The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信